

UK EXECUTIVE CHANGE SUMMARY: Primorus Adds Three Directors To Board


UK WINNERS & LOSERS SUMMARY: Provident Financial Up On Better Outlook


4D Pharma Says Results In MRx0518, Keytruda Cancer Trial "Encouraging"


UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech


4D Pharma To Raise GBP7.7 Million In Share Issue, Eyes US Listing


(Sharecast News) - Biotherapeutics developer 4D Pharma has begin the treatment of the first patients in part B of its phase 1 and 2 clinical trial of ...


4D Pharma Starts Treatment Of Patients In Phase 2 Of MRx0518 Trial


(Sharecast News) - Biotherapeutics-focussed pharmaceutical company 4D Pharma announced on Thursday that its phase 2 clinical trial of the oral immunom...